시장보고서
상품코드
1618257

세계의 안면 임플란트 시장 : 인사이트, 경쟁 구도, 시장 예측(-2030년)

Facial Implants - Market Insights, Competitive Landscape, and Market Forecast - 2030

발행일: | 리서치사: DelveInsight | 페이지 정보: 영문 150 Pages | 배송안내 : 2-10일 (영업일 기준)

    
    
    




■ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송일정은 문의해 주시기 바랍니다.

안면 임플란트 시장 규모는 2023년 25억 6,000만 달러에서 예측 기간 동안 CAGR 8.02%로 추이하고, 2030년에는 40억 6,000만 달러 규모로 성장할 것으로 예측됩니다.

이 시장은 치과 질환을 포함한 급성 및 만성 질환 사례 증가, 제품 개발 활동 증가, 낮은 침습 처치가 선호되는 경향이 높아지고, 다양한 얼굴 임플란트의 가용성에 의해 현저한 성장을 경험하고 있습니다.

안면 임플란트: 시장 역학

World Health Organization(WHO)의 Global Oral Health Status Report(2022) 최근의 추계에 따르면, 구강 질환은 세계에서 약 35억명을 괴롭히고 있으며, 중소득국가 4건 중 3건을 차지하고 있습니다. 어린이는 유치의 충치가 있고, 세계에서 추정 20억 명의 성인이 영구치의 충치가 있다고 보여줍니다.

또한 WHO(2023) 는 세계 인구의 약 19%에 해당하는 10억 명 이상의 성인이 심한 치주병을 앓고 있다고 말합니다. 제거 및 치주병 치료를 위한 저침습으로 정밀한 치료를 제공하기 위해 레이저 개입이 효율적이고 환자 친화적인 치료의 필요성이 높아져 안면 임플란트 시장을 강화하고 있습니다.

제품 유형별로는 턱·하악 임플란트가 2023년에 큰 시장 점유율을 차지할 것으로 예측되고 있습니다. 구강암에서는 종양이 뼈에 매우 가깝거나 붙어있는 경우, 하악 절제술이 수행됩니다.

지역별로는 북미가 안면 임플란트 시장에서 큰 수익 점유율을 차지할 것으로 추산되고 있습니다. 이는 심미적 치료에 대한 요구가 증가하고, 침습성이 낮은 치료에 대한 수요가 증가하고, 기술이 지속적으로 발전하는 등의 요인에 기인합니다.

이 보고서는 세계 안면 임플란트 시장을 조사했으며, 시장 개요, 시장 영향요인 및 시장 기회 분석, 법규제 환경, 시장 규모 추이와 예측, 각종 구분·지역/주요 국가별 상세 분석, 경쟁 정세, 주요 기업 프로파일 등을 정리했습니다.

목차

제1장 안면 임플란트 시장 보고서 : 인트로덕션

  • 조사 범위
  • 시장 분류
  • 시장의 상정

제2장 안면 임플란트 시장 : 주요 요약

  • 시장 개요

제3장 경쟁 구도

제4장 규제 분석

  • 미국
  • 유럽
  • 일본
  • 중국

제5장 안면 임플란트 시장 : 주요 요인 분석

  • 시장 성장 촉진요인
    • 급성 및 만성질환 증가
    • 제품 개발 활동의 활성화
    • 낮은 침습 수술의 호감도가 증가
    • 다양한 유형의 안면 임플란트가 이용 가능
  • 시장 성장 억제요인과 과제
    • 안면 임플란트와 관련된 잠재적 위험
    • 안면 증강 수술에 따른 고액의 비용
  • 시장 기회
    • 로봇 지원 레이저 수술의 인기
    • 3D 프린팅 안면 임플란트 개발

제6장 안면 임플란트 시장 : Porter's Five Forces 분석

제7장 안면 임플란트 시장 평가

  • 제품 유형별
    • 턱·하악 임플란트
    • 광대골 및 광골하 임플란트
    • 코 임플란트
    • 주입형 임플란트
    • 기타
  • 소재별
    • 금속
    • 실리콘
    • PTFE
    • 폴리에틸렌
  • 용도별
    • 턱의 증강
    • 광대뼈 수술
    • 코 성형술
  • 최종 사용자별
    • 병원
    • 전문 클리닉
  • 지역별
    • 북미
    • 유럽
    • 아시아태평양
    • 기타 지역

제8장 안면 임플란트 시장 : 기업?제품 프로파일

  • Medartis AG
  • Eurosurgical Ltd.
  • AbbVie Inc.
  • Guangzhou Wanhe Plastic Materials Co., Ltd.
  • Sebbin
  • Hanson Medical Inc.
  • POLYTECH Health & Aesthetics GmbH
  • SurgiSil
  • Implantech
  • Surgiform Technologies LLC
  • Xilloc Medical Int BV
  • Ortho Baltic
  • Stryker
  • GALDERMA
  • Suneva Medical

제9장 KOL의 견해

제10장 프로젝트 접근법

제11장 DelveInsight 정보

제12장 면책사항 및 문의

JHS 25.01.09

Facial Implants Market by Product Type (Chin & Mandibular Implants, Malar & Submalar Implants, Nasal Implants, Injectable Implants, and Others), Material (Metals, Silicone, ePTFE, Polyethylene, and Others), Application (Chin Augmentation, Cheek Bone Surgery, Rhinoplasty, and Others), End-User (Hospitals, Specialty Clinics, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to advance at a substantial CAGR forecast till 2030 owing to the increasing instances of acute & chronic disorders and the rising product developmental activities across the globe

The facial implants market was valued at USD 2.56 billion in 2023, growing at a CAGR of 8.02% during the forecast period from 2024 to 2030 to reach USD 4.06 billion by 2030. The facial implants market is experiencing significant growth due to the increasing instances of acute & chronic disorders including dental disorders, rising product developmental activities, growing preference for minimally invasive procedures, and availability of a wide variety of facial implants that are acting as major factors contributing to the overall growth of the facial implants market during the forecast period from 2024 to 2030.

Facial Implants Market Dynamics:

According to recent estimates from the World Health Organization (WHO), Global Oral Health Status Report (2022), oral illnesses afflict around 3.5 billion people globally, with middle-income nations accounting for three out of every four cases. The source further highlighted that 514 million children worldwide suffered from primary tooth caries, whereas an estimated 2 billion adults worldwide suffered from caries of permanent teeth annually on average.

Additionally, WHO (2023), stated that more than 1 billion adults, about 19% of the global population, are affected by severe periodontal diseases. The chief risk factor for this disease is the use of tobacco. Facial implants offer minimally invasive, precise treatments for tooth caries removal and periodontal care, making laser interventions a growing necessity for efficient, patient-friendly care and thereby bolstering the market for facial implants.

Various product developmental activities by key market players will further boost the market for same. For instance, in September 2024, Allergan Aesthetics launched BOTOX(R) Cosmetic (onabotulinumtoxinA) for Masseter Muscle Prominence (MMP) in Adults in China.

Hence, the interplay of all the above-mentioned factors is expected to drive the overall facial implants market during the given forecast period from 2024 to 2030.

However, potential risks associated with facial implants, high cost associated with facial augmentation procedures, and others may restrict the market growth for the facial implants market.

Facial Implants Market Segment Analysis:

Facial Implants Market by Product Type (Chin & Mandibular Implants, Malar & Submalar Implants, Nasal Implants, Injectable Implants, and Others), Material (Metals, Silicone, ePTFE, Polyethylene, and Others), Application (Chin Augmentation, Cheek Bone Surgery, Rhinoplasty, and Others), End-User (Hospitals, Specialty Clinics, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the product type segment of the facial implants market, the chin & mandibular implant is anticipated to hold a significant market share in 2023. This is because of the rising cases of oral cancer among the population across the globe. In oral cancer when the tumor is very close or attached to the bone, mandibular resection is performed. Mandibular resection is most common for mouth cancers that begin in the lower gums or the sublingual space. For instance, according to the Global Cancer Observatory 2024, it projected that approximately 600k new cases of oral cancer will be registered by 2045. Thus, the rising oral cancer cases are likely to increase segment growth.

In addition to the above factors, the incorporation of advanced technology in the product portfolio is also one of the key factors contributing to the market growth of facial implants. For instance, in September 2021, 3D Anatomical Construction Laboratory (LARA 3D), a provincial research institute was issued Health Canada approval for its 3D printed Specifit 3D mandibular plate.

Therefore, the widespread uses and various advantages of chin & mandibular implants that enhance performance and usability will solidify the impact on the growth of the overall facial implants market during the forecast period from 2024 to 2030.

North America is expected to dominate the overall facial implants market:

Among all the regions, North America is estimated to hold a significant revenue share in the facial implants market. This can be attributed to several factors including the rising need for aesthetic procedures, rising demand for minimally invasive treatments, and the continuous advancements in technology, that act as major factors contributing to the growth of the facial implants market in the North America region during the forecast period from 2024 to 2030.

As per data by the International Society of Aesthetic Plastic Surgery (2023), the total number of aesthetic procedures that took place in the US was 6,196,701, including both surgical and non-surgical procedures. The US was also the country with the highest number of non-surgical procedures worldwide in 2023, with 4,405,599 procedures in 2023. The source further stated that the US was the country with the highest number of aesthetic surgeons globally, with 7,750 surgeons in 2023.

In addition, as per the Global Survey (2022), in 2021, the US performed the most aesthetic procedures worldwide, accounting for 24.1% of the total procedures performed globally, with 30.4% of all non-surgical procedures and 15.5% of all surgical procedures. In 2022, the US performed over 7.4 million aesthetic procedures, which was 22% of the global number of procedures performed in 2022. The top five most popular surgical procedures in the US were liposuction, breast augmentation, eyelid surgery, rhinoplasty, and abdominoplasty, with botulinum toxin being the most common non-surgical procedure in 2022 in the US across all age groups.

As people seek both non-surgical and surgical options, interest in long-lasting facial contouring solutions, like implants, is growing. This trend supports a steady rise in facial implant demand.

Various product developmental strategies such as clearances in the region by regulatory authorities in the region play a major role in pushing forward the revenue shares of Facial Implants in the region. For example, in March 2024, the FDA approved filler for temple hollows the first and only hyaluronic acid filler with this indication.

Moreover, product launches by key market players in the region is further expected to propel the growth of the North America Facial Implants market.

Therefore, the interplay of all the factors mentioned above would provide a conducive growth environment for the North America region in the facial implants market during the forecast period from 2024 to 2030.

Facial Implants Market key players:

Some of the key market players operating in the facial implants market include Medartis AG, Eurosurgical Ltd., AbbVie Inc., Guangzhou Wanhe Plastic Materials Co., Ltd., Sebbin, Hanson Medical Inc., POLYTECH Health & Aesthetics GmbH, SurgiSil, Implantech, Surgiform Technologies LLC, Xilloc Medical Int B.V., Ortho Baltic, Stryker, GALDERMA, Suneva Medical, and others.

Recent Developmental Activities in the Facial Implants Market:

  • In August 2022, Bengaluru-based Allergan Healthcare India launched Juvederm VOLUX, an injectable implant intended to restore and create the volume of the face in India under its Business Unit of Allergan Aesthetics.
  • In February 2021, Galderma received the US Food and Drug Administration (FDA) approval Restylane(R) Defyne for the augmentation and correction of mild to moderate chin retrusion for adults over the age of 21.

Key takeaways from the Facial Implants market report study

  • Market size analysis for current facial implants market size (2023), and market forecast for 6 years (2024 to 2030)
  • Top key product/services developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
  • Key companies dominating the Facial Implants market
  • Various opportunities available for other competitors in the facial implants market space
  • What are the top-performing segments in 2023? How these segments will perform in 2030?
  • Which are the top-performing regions and countries in the current facial implants market scenario?
  • Which are the regions and countries where companies should have concentrated on opportunities for facial implants market growth in the coming future?

Target audience who can be benefited from this Facial Implants market report study

  • Facial implants providers
  • Research organizations and consulting companies
  • Facial implants-related organizations, associations, forums, and other alliances
  • Government and corporate offices
  • Start-up companies, venture capitalists, and private equity firms
  • Distributors and traders dealing in facial implants
  • Various end-users who want to know more about the facial implants market and the latest developments in the facial implants market

Frequently Asked Questions for the Facial Implants Market:

1. What are facial implants?

  • The facial implants are specially designed solid materials compatible with human tissues to enhance or augment the physical structure of the face. They offer a three-dimensional, permanent (when fixated) solution to volume restoration in the middle and lower face and can be serviced or removed without maximally invasive surgery.

2. What is the market for facial implants?

  • The facial implants market was valued at USD 2.56 billion in 2023, growing at a CAGR of 8.02% during the forecast period from 2024 to 2030 to reach USD 4.06 billion by 2030.

3. What are the drivers for the facial implant market?

  • The facial implants market is experiencing significant growth due to the increasing instances of acute & chronic disorders including dental disorders, rising product developmental activities, growing preference for minimally invasive procedures, and availability of a wide variety of Facial Implants that are acting as major factors contributing to the overall growth of the facial implants market during the forecast period from 2024 to 2030.

4. Who are the key players operating in the facial implants market?

  • Some of the major market players operating in the facial implants market include Medartis AG, Eurosurgical Ltd., AbbVie Inc., Guangzhou Wanhe Plastic Materials Co., Ltd., Sebbin, Hanson Medical Inc., POLYTECH Health & Aesthetics GmbH, SurgiSil, Implantech, Surgiform Technologies LLC, Xilloc Medical Int B.V., Ortho Baltic, Stryker, GALDERMA, Suneva Medical, and others.

5. Which region has the highest share in the facial implants market?

  • Among all the regions, North America is estimated to hold a significant revenue share in the facial implants market. This can be attributed to several factors including the rising need for aesthetic procedures, rising demand for minimally invasive treatments, and the continuous advancements in technology, which offers improved treatment features and efficiency, that are acting as major factors contributing to the growth of the facial implants market in the North America region during the forecast period from 2024 to 2030.

Table of Contents

1. Facial Implants Market Report Introduction

  • 1.1. Scope of the Study
  • 1.2. Market Segmentation
  • 1.3. Market Assumption

2. Facial Implants Market Executive Summary

  • 2.1. Market at Glance

3. Competitive Landscape

4. Regulatory Analysis

  • 4.1. The United States
  • 4.2. Europe
  • 4.3. Japan
  • 4.4. China

5. Facial Implants Market Key Factors Analysis

  • 5.1. Facial Implants Market Drivers
    • 5.1.1. Increasing instances of acute and chronic disorders
    • 5.1.2. Rising product developmental activities
    • 5.1.3. Growing preference of minimally invasive procedure
    • 5.1.4. Availability of wide variety facial implants
  • 5.2. Facial Implants Market Restraints and Challenges
    • 5.2.1. Potential risk associated with facial implants
    • 5.2.2. High cost associated with facial augmentation procedures
  • 5.3. Facial Implants Market Opportunities
    • 5.3.1. Growing popularity of robot-assisted laser surgeries
    • 5.3.2. Development of 3D printed facial implants

6. Facial Implants Market Porter's Five Forces Analysis

  • 6.1. Bargaining Power of Suppliers
  • 6.2. Bargaining Power of Consumers
  • 6.3. Threat of New Entrants
  • 6.4. Threat of Substitutes
  • 6.5. Competitive Rivalry

7. Facial Implants Market Assessment

  • 7.1. By Product Type
    • 7.1.1. Chin & Mandibular Implants
    • 7.1.2. Malar & Submalar Implants
    • 7.1.3. Nasal Implants
    • 7.1.4. Injectable Implants
    • 7.1.5. Others
  • 7.2. By Material
    • 7.2.1. Metal
    • 7.2.2. Silicone
    • 7.2.3. ePTFE
    • 7.2.4. Polyethylene
    • 7.2.5. Others
  • 7.3. By Application
    • 7.3.1. Chin augmentation
    • 7.3.2. Cheek Bone surgery
    • 7.3.3. Rhinoplasty
    • 7.3.4. Others
  • 7.4. By End-User
    • 7.4.1. Hospitals
    • 7.4.2. Specialty Clinics
    • 7.4.3. Others
  • 7.5. By Geography
    • 7.5.1. North America
      • 7.5.1.1. United States Facial Implants Market Size in USD million (2021-2030)
      • 7.5.1.2. Canada Facial Implants Market Size in USD million (2021-2030)
      • 7.5.1.3. Mexico Facial Implants Market Size in USD million (2021-2030)
    • 7.5.2. Europe
      • 7.5.2.1. France Facial Implants Market Size in USD million (2021-2030)
      • 7.5.2.2. Germany Facial Implants Market Size in USD million (2021-2030)
      • 7.5.2.3. United Kingdom Facial Implants Market Size in USD million (2021-2030)
      • 7.5.2.4. Italy Facial Implants market size in USD million (2021-2030)
      • 7.5.2.5. Spain Facial Implants Market Size in USD million (2021-2030)
      • 7.5.2.6. Rest of Europe Facial Implants Market Size in USD million (2021-2030)
    • 7.5.3. Asia-Pacific
      • 7.5.3.1. China Facial Implants Market Size in USD million (2021-2030)
      • 7.5.3.2. Japan Facial Implants Market Size in USD million (2021-2030)
      • 7.5.3.3. India Facial Implants Market Size in USD million (2021-2030)
      • 7.5.3.4. Australia Facial Implants Market Size in USD million (2021-2030)
      • 7.5.3.5. South Korea Facial Implants Market Size in USD million (2021-2030)
      • 7.5.3.6. Rest of Asia-Pacific Facial Implants Market Size in USD million (2021-2030)
    • 7.5.4. Rest of the World (RoW)
      • 7.5.4.1. Middle East Facial Implants Market Size in USD million (2021-2030)
      • 7.5.4.2. Africa Facial Implants Market Size in USD million (2021-2030)
      • 7.5.4.3. South America Facial Implants Market Size in USD million (2021-2030)

8. Facial Implants Market Company and Product Profiles

  • 8.1. Medartis AG
    • 8.1.1. Company Overview
    • 8.1.2. Company Snapshot
    • 8.1.3. Financial Overview
    • 8.1.4. Product Listing
    • 8.1.5. Entropy
  • 8.2. Eurosurgical Ltd.
    • 8.2.1. Company Overview
    • 8.2.2. Company Snapshot
    • 8.2.3. Financial Overview
    • 8.2.4. Product Listing
    • 8.2.5. Entropy
  • 8.3. AbbVie Inc.
    • 8.3.1. Company Overview
    • 8.3.2. Company Snapshot
    • 8.3.3. Financial Overview
    • 8.3.4. Product Listing
    • 8.3.5. Entropy
  • 8.4. Guangzhou Wanhe Plastic Materials Co., Ltd.
    • 8.4.1. Company Overview
    • 8.4.2. Company Snapshot
    • 8.4.3. Financial Overview
    • 8.4.4. Product Listing
    • 8.4.5. Entropy
  • 8.5. Sebbin
    • 8.5.1. Company Overview
    • 8.5.2. Company Snapshot
    • 8.5.3. Financial Overview
    • 8.5.4. Product Listing
    • 8.5.5. Entropy
  • 8.6. Hanson Medical Inc.
    • 8.6.1. Company Overview
    • 8.6.2. Company Snapshot
    • 8.6.3. Financial Overview
    • 8.6.4. Product Listing
    • 8.6.5. Entropy
  • 8.7. POLYTECH Health & Aesthetics GmbH
    • 8.7.1. Company Overview
    • 8.7.2. Company Snapshot
    • 8.7.3. Financial Overview
    • 8.7.4. Product Listing
    • 8.7.5. Entropy
  • 8.8. SurgiSil
    • 8.8.1. Company Overview
    • 8.8.2. Company Snapshot
    • 8.8.3. Financial Overview
    • 8.8.4. Product Listing
    • 8.8.5. Entropy
  • 8.9. Implantech
    • 8.9.1. Company Overview
    • 8.9.2. Company Snapshot
    • 8.9.3. Financial Overview
    • 8.9.4. Product Listing
    • 8.9.5. Entropy
  • 8.10. Surgiform Technologies LLC
    • 8.10.1. Company Overview
    • 8.10.2. Company Snapshot
    • 8.10.3. Financial Overview
    • 8.10.4. Product Listing
    • 8.10.5. Entropy
  • 8.11. Xilloc Medical Int B.V.
    • 8.11.1. Company Overview
    • 8.11.2. Company Snapshot
    • 8.11.3. Financial Overview
    • 8.11.4. Product Listing
    • 8.11.5. Entropy
  • 8.12. Ortho Baltic
    • 8.12.1. Company Overview
    • 8.12.2. Company Snapshot
    • 8.12.3. Financial Overview
    • 8.12.4. Product Listing
    • 8.12.5. Entropy
  • 8.13. Stryker
    • 8.13.1. Company Overview
    • 8.13.2. Company Snapshot
    • 8.13.3. Financial Overview
    • 8.13.4. Product Listing
    • 8.13.5. Entropy
  • 8.14. GALDERMA
    • 8.14.1. Company Overview
    • 8.14.2. Company Snapshot
    • 8.14.3. Financial Overview
    • 8.14.4. Product Listing
    • 8.14.5. Entropy
  • 8.15. Suneva Medical
    • 8.15.1. Company Overview
    • 8.15.2. Company Snapshot
    • 8.15.3. Financial Overview
    • 8.15.4. Product Listing
    • 8.15.5. Entropy

9. KOL Views

10. Project Approach

11. About DelveInsight

12. Disclaimer & Contact Us

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제